EAM
IART icon

Exos Asset Management’s Integra LifeSciences IART Stock Holding History

Exos Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,242
Closed -$85K – 574
2021
Q2 		$85K Buy
+1,242
New +$87.8K 0.04% 394

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Exos Asset Management's IART Position: Q3 2021 in Review

Exos Asset Management sold out of Integra LifeSciences (IART) in Q3 2021, closing a stake of 1,242 shares — an estimated $85K sold.

Exos Asset Management first reported a position in IART in Q2 2021 and held it in 1 quarter. The position peaked at $85K in Q2 2021. 261 funds tracked by Wall St. Rank hold IART as of Q3 2021.

  • Exos Asset Management reported no remaining Integra LifeSciences position as of Q3 2021 after selling out during the quarter.
  • Exos Asset Management sold 1,242 Integra LifeSciences shares in Q3 2021, an estimated $85K.
  • Exos Asset Management first reported a position in Integra LifeSciences in Q2 2021 and held it in 1 quarter.
  • Exos Asset Management's Integra LifeSciences position peaked at $85K in Q2 2021.
  • 261 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.